Nuveen’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-715,115
| Closed | -$131M | – | 3480 |
|
|
2021
Q2 | $131M | Sell |
715,115
-37,508
| -5% | -$6.44M | 0.04% | 395 |
|
|
2021
Q1 | $115M | Sell |
752,623
-36,763
| -5% | -$5.69M | 0.04% | 418 |
|
|
2020
Q4 | $123M | Sell |
789,386
-224,620
| -22% | -$28.9M | 0.04% | 382 |
|
|
2020
Q3 | $116M | Sell |
1,014,006
-184,872
| -15% | -$19.9M | 0.04% | 335 |
|
|
2020
Q2 | $135M | Sell |
1,198,878
-288,885
| -19% | -$30.7M | 0.05% | 290 |
|
|
2020
Q1 | $134M | Sell |
1,487,763
-28,386
| -2% | -$2.79M | 0.07% | 256 |
|
|
2019
Q4 | $164M | Buy |
1,516,149
+295,356
| +24% | +$31.6M | 0.06% | 292 |
|
|
2019
Q3 | $120M | Sell |
1,220,793
-2,416,351
| -66% | -$272M | 0.05% | 360 |
|
|
2019
Q2 | $476M | Buy |
3,637,144
+3,630,846
| +57,651% | +$468M | 0.19% | 104 |
|
|
2019
Q1 | $851K | Buy |
6,298
+117
| +2% | +$14.5K | ﹤0.01% | 767 |
|
|
2018
Q4 | $602K | Buy |
6,181
+110
| +2% | +$13K | ﹤0.01% | 792 |
|
|
2018
Q3 | $844K | Sell |
6,071
-176
| -3% | -$22.1K | ﹤0.01% | 772 |
|
|
2018
Q2 | $776K | Sell |
6,247
-236
| -4% | -$27.6K | ﹤0.01% | 791 |
|
|
2018
Q1 | $723K | Sell |
6,483
-159,559
| -96% | -$19.1M | ﹤0.01% | 819 |
|
|
2017
Q4 | $19.9M | Buy |
166,042
+77,619
| +88% | +$9.45M | 0.13% | 243 |
|
|
2017
Q3 | $12.4M | Sell |
88,423
-11,321
| -11% | -$1.54M | 0.08% | 353 |
|
|
2017
Q2 | $12.1M | Buy |
99,744
+1,132
| +1% | +$132K | 0.08% | 361 |
|
|
2017
Q1 | $12M | Buy |
98,612
+19,775
| +25% | +$2.55M | 0.07% | 381 |
|
|
2016
Q4 | $9.65M | Sell |
78,837
-22,686
| -22% | -$2.78M | 0.05% | 469 |
|
|
2016
Q3 | $12.4M | Sell |
101,523
-805
| -0.8% | -$104K | 0.07% | 329 |
|
|
2016
Q2 | $11.9M | Buy |
102,328
+79,074
| +340% | +$11.2M | 0.07% | 322 |
|
|
2016
Q1 | $3.24K | Sell |
23,254
-40,482
| -64% | -$5.94M | 0.02% | 595 |
|
|
2015
Q4 | $12.2K | Buy |
63,736
+4,552
| +8% | +$795K | 0.06% | 299 |
|
|
2015
Q3 | $9.26K | Sell |
59,184
-400
| -0.7% | -$73K | 0.05% | 346 |
|
|
2015
Q2 | $10.8K | Sell |
59,584
-70,133
| -54% | -$12.1M | 0.06% | 364 |
|
|
2015
Q1 | $22.5M | Sell |
129,717
-1,286
| -1% | -$233K | 0.12% | 235 |
|
|
2014
Q4 | $24.2M | Sell |
131,003
-10,860
| -8% | -$2.01M | 0.14% | 208 |
|
|
2014
Q3 | $23.5M | Buy |
141,863
+2,513
| +2% | +$413K | 0.15% | 189 |
|
|
2014
Q2 | $21.8M | Sell |
139,350
-60,890
| -30% | -$9.61M | 0.13% | 208 |
|
|
2014
Q1 | $30.5M | Buy |
200,240
+1,003
| +0.5% | +$159K | 0.19% | 126 |
|
|
2013
Q4 | $26.5M | Buy |
199,237
+56,554
| +40% | +$6.79M | 0.18% | 168 |
|
|
2013
Q3 | $16.6M | Buy |
142,683
+127,351
| +831% | +$14M | 0.11% | 252 |
|
|
2013
Q2 | $1.41M | Buy |
+15,332
| New | +$1.48M | 0.01% | 892 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM